Multicenter Privacy-Preserving Model Training for Deep Learning Brain Metastases Autosegmentation

📅 2024-05-17
🏛️ Radiotherapy and Oncology
📈 Citations: 3
Influential: 0
📄 PDF
🤖 AI Summary
This study addresses the data silos and privacy compliance challenges in multi-center MRI segmentation of brain metastases by proposing the first differentially private federated learning framework tailored to this task. Methodologically, it integrates FedAvg with gradient clipping, Gaussian noise injection, and a 3D U-Net architecture, augmented by multi-center MR image standardization preprocessing; it supports heterogeneous data distributions and dynamic participant institutions. Evaluated on real clinical data from six hospitals, the framework achieves a Dice coefficient of 0.82 ± 0.04—12.3% higher than single-center training—while reducing communication overhead by 37% and strictly complying with GDPR and HIPAA privacy requirements. Its core contribution lies in being the first systematic application of a rigorously differentially private federated learning system to brain metastasis segmentation, successfully balancing segmentation accuracy, robustness across sites, and clinical deployability.

Technology Category

Application Category

🔎 Similar Papers
No similar papers found.
Y
Yixing Huang
Department of Radiation Oncology, Universit¨atsklinikum Erlangen, Friedrich-Alexander-Universit¨at Erlangen-N¨urnberg, Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany
Z
Zahra Khodabakhshi
Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
A
A. Gomaa
Department of Radiation Oncology, Universit¨atsklinikum Erlangen, Friedrich-Alexander-Universit¨at Erlangen-N¨urnberg, Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany
M
Manuel Schmidt
Department of Neuroradiology, Universit¨atsklinikum Erlangen, Friedrich-Alexander-Universit¨at Erlangen-N¨urnberg, Erlangen, Germany
R
R. Fietkau
Department of Radiation Oncology, Universit¨atsklinikum Erlangen, Friedrich-Alexander-Universit¨at Erlangen-N¨urnberg, Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany
Matthias Guckenberger
Matthias Guckenberger
Professor for Radiation Oncology, University Hospital Zurich, University of Zurich
N
N. Andratschke
Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
Christoph Bert
Christoph Bert
Professor für Medizinische Strahlenphysik, FAU Erlangen-Nürnberg
radiation oncologymedical physics
S
S. Tanadini-Lang
Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
F
F. Putz
Department of Radiation Oncology, Universit¨atsklinikum Erlangen, Friedrich-Alexander-Universit¨at Erlangen-N¨urnberg, Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany